ReP USP - Resultado da busca

Artigo de periodico
COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group (2024)
Panchawagh, Suhrud; Ravichandran, Naveen; Barman, Bhupen; Nune, Arvind; Javaid, Mahnoor; Gracia-Ramos, Abraham Edgar; Day, Jessica; Joshi, Mrudula; Kuwana, Masataka; Shinjo, Samuel Katsuyuki
Fonte: Rheumatology international. Unidade: FM
Assuntos: COVID-19, DIABETES MELLITUS, VACINAÇÃO, ESTUDOS TRANSVERSAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PANCHAWAGH, Suhrud et al. COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group. Rheumatology international, v. 44, n. 1, p. 73-80, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/58770. Acesso em: 25 jun. 2025.
APA
Panchawagh, S., Ravichandran, N., Barman, B., Nune, A., Javaid, M., Gracia-Ramos, A. E., et al. (2024). COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group. Rheumatology international, 44( 1), 73-80. doi:10.1007/s00296-023-05496-y
NLM
Panchawagh S, Ravichandran N, Barman B, Nune A, Javaid M, Gracia-Ramos AE, Day J, Joshi M, Kuwana M, Shinjo SK. COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group [Internet]. Rheumatology international. 2024 ; 44( 1): 73-80.[citado 2025 jun. 25 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58770
Vancouver
Panchawagh S, Ravichandran N, Barman B, Nune A, Javaid M, Gracia-Ramos AE, Day J, Joshi M, Kuwana M, Shinjo SK. COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group [Internet]. Rheumatology international. 2024 ; 44( 1): 73-80.[citado 2025 jun. 25 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58770
Artigo de periodico
Listening to patients, for the patients: the COVAD Study-Vision, organizational structure, and challenges (2024)
Joshi, Mrudula; Darooka, Naitica; Saha, Sreoshy; Dyball, Sarah; Sen, Parikshit; Yaadav, Praggya; Javaid, Mahnoor; Kadam, Esha; Shinjo, Samuel Katsuyuki ; Dey, Dzifa
Fonte: International journal of rheumatic diseases. Unidade: FM
Assuntos: REUMATOLOGIA, VOZ, COVID-19, QUESTIONÁRIOS, ÍNDIA, MÉXICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JOSHI, Mrudula et al. Listening to patients, for the patients: the COVAD Study-Vision, organizational structure, and challenges. International journal of rheumatic diseases, v. 27, n. 5, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/76828. Acesso em: 25 jun. 2025.
APA
Joshi, M., Darooka, N., Saha, S., Dyball, S., Sen, P., Yaadav, P., et al. (2024). Listening to patients, for the patients: the COVAD Study-Vision, organizational structure, and challenges. International journal of rheumatic diseases, 27( 5). doi:10.1111/1756-185X.15161
NLM
Joshi M, Darooka N, Saha S, Dyball S, Sen P, Yaadav P, Javaid M, Kadam E, Shinjo SK, Dey D. Listening to patients, for the patients: the COVAD Study-Vision, organizational structure, and challenges [Internet]. International journal of rheumatic diseases. 2024 ; 27( 5):[citado 2025 jun. 25 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76828
Vancouver
Joshi M, Darooka N, Saha S, Dyball S, Sen P, Yaadav P, Javaid M, Kadam E, Shinjo SK, Dey D. Listening to patients, for the patients: the COVAD Study-Vision, organizational structure, and challenges [Internet]. International journal of rheumatic diseases. 2024 ; 27( 5):[citado 2025 jun. 25 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76828
Artigo de periodico
Flares of autoimmune rheumatic disease following COVID-19 infection: Observations from the COVAD study (2024)
Sandhu, Nimrat Kaur; Ravichandran, Naveen ; Nune, Arvind; Day, Jessica ; Sen, Parikshit ; Nikiphorou, Elena ; Tan, Ai Lyn; Joshi, Mrudula; Saha, Sreoshy ; Shinjo, Samuel Katsuyuki
Fonte: INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES. Unidade: FM
Assuntos: COVID-19, DOENÇAS AUTOIMUNES, DOENÇAS REUMÁTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANDHU, Nimrat Kaur et al. Flares of autoimmune rheumatic disease following COVID-19 infection: Observations from the COVAD study. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, v. 27, n. 1, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57853. Acesso em: 25 jun. 2025.
APA
Sandhu, N. K., Ravichandran, N., Nune, A., Day, J., Sen, P., Nikiphorou, E., et al. (2024). Flares of autoimmune rheumatic disease following COVID-19 infection: Observations from the COVAD study. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 27( 1). doi:10.1111/1756-185X.14961
NLM
Sandhu NK, Ravichandran N, Nune A, Day J, Sen P, Nikiphorou E, Tan AL, Joshi M, Saha S, Shinjo SK. Flares of autoimmune rheumatic disease following COVID-19 infection: Observations from the COVAD study [Internet]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES. 2024 ; 27( 1):[citado 2025 jun. 25 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57853
Vancouver
Sandhu NK, Ravichandran N, Nune A, Day J, Sen P, Nikiphorou E, Tan AL, Joshi M, Saha S, Shinjo SK. Flares of autoimmune rheumatic disease following COVID-19 infection: Observations from the COVAD study [Internet]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES. 2024 ; 27( 1):[citado 2025 jun. 25 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57853
Artigo de periodico
Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study (2024)
Chatterjee, Tulika; Ravichandran, Naveen ; Nair, Narmadha; Gracia-Ramos, Abraham Edgar; Barman, Bhupen; Sen, Parikshit ; Joshi, Mrudula; Saha, Sreoshy ; Nune, Arvind; Pande, Arun Kumar R; Shinjo, Samuel Katsuyuki
Fonte: JOURNAL OF DIABETES INVESTIGATION. Unidade: FM
Assuntos: COVID-19, DIABETES MELLITUS INSULINO-DEPENDENTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHATTERJEE, Tulika et al. Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study. JOURNAL OF DIABETES INVESTIGATION, v. 15, n. 1, p. 131-138, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57840. Acesso em: 25 jun. 2025.
APA
Chatterjee, T., Ravichandran, N., Nair, N., Gracia-Ramos, A. E., Barman, B., Sen, P., et al. (2024). Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study. JOURNAL OF DIABETES INVESTIGATION, 15( 1), 131-138. doi:10.1111/jdi.14079
NLM
Chatterjee T, Ravichandran N, Nair N, Gracia-Ramos AE, Barman B, Sen P, Joshi M, Saha S, Nune A, Pande AKR, Shinjo SK. Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study [Internet]. JOURNAL OF DIABETES INVESTIGATION. 2024 ; 15( 1): 131-138.[citado 2025 jun. 25 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57840
Vancouver
Chatterjee T, Ravichandran N, Nair N, Gracia-Ramos AE, Barman B, Sen P, Joshi M, Saha S, Nune A, Pande AKR, Shinjo SK. Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study [Internet]. JOURNAL OF DIABETES INVESTIGATION. 2024 ; 15( 1): 131-138.[citado 2025 jun. 25 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57840
Artigo de periodico
Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey (2024)
Ahmed, Sakir; Gupta, Latika; Kuwana, Masataka; Pauling, John D; Day, Jessica; Ravichandran, Naveen; Joshi, Mrudula; Parodis, Ioannis; Sen, Parikshit; Shinjo, Samuel Katsuyuki
Fonte: Rheumatology international. Unidade: FM
Assuntos: DOENÇAS AUTOIMUNES, COVID-19, QUESTIONÁRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AHMED, Sakir et al. Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey. Rheumatology international, v. 44, n. 1, p. 89-97, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/76832. Acesso em: 25 jun. 2025.
APA
Ahmed, S., Gupta, L., Kuwana, M., Pauling, J. D., Day, J., Ravichandran, N., et al. (2024). Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey. Rheumatology international, 44( 1), 89-97. doi:10.1007/s00296-023-05433-z
NLM
Ahmed S, Gupta L, Kuwana M, Pauling JD, Day J, Ravichandran N, Joshi M, Parodis I, Sen P, Shinjo SK. Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey [Internet]. Rheumatology international. 2024 ; 44( 1): 89-97.[citado 2025 jun. 25 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76832
Vancouver
Ahmed S, Gupta L, Kuwana M, Pauling JD, Day J, Ravichandran N, Joshi M, Parodis I, Sen P, Shinjo SK. Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey [Internet]. Rheumatology international. 2024 ; 44( 1): 89-97.[citado 2025 jun. 25 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76832
Artigo de periodico
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey (2023)
Hoff, Leonardo Santos; Ravichandran, Naveen; Shinjo, Samuel Katsuyuki ; Day, Jessica; Sen, Parikshit; Junior, Jucier Goncalves; Lilleker, James B.; Joshi, Mrudula; Agarwal, Vishwesh; Kardes, Sinan
Fonte: RHEUMATOLOGY INTERNATIONAL. Unidade: FM
Assuntos: COVID-19, INFECÇÕES POR CORONAVIRUS, DOENÇAS AUTOIMUNES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOFF, Leonardo Santos et al. COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey. RHEUMATOLOGY INTERNATIONAL, v. 43, n. 1, p. 47-58, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57854. Acesso em: 25 jun. 2025.
APA
Hoff, L. S., Ravichandran, N., Shinjo, S. K., Day, J., Sen, P., Junior, J. G., et al. (2023). COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey. RHEUMATOLOGY INTERNATIONAL, 43( 1), 47-58. doi:10.1007/s00296-022-05229-7
NLM
Hoff LS, Ravichandran N, Shinjo SK, Day J, Sen P, Junior JG, Lilleker JB, Joshi M, Agarwal V, Kardes S. COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey [Internet]. RHEUMATOLOGY INTERNATIONAL. 2023 ; 43( 1): 47-58.[citado 2025 jun. 25 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57854
Vancouver
Hoff LS, Ravichandran N, Shinjo SK, Day J, Sen P, Junior JG, Lilleker JB, Joshi M, Agarwal V, Kardes S. COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey [Internet]. RHEUMATOLOGY INTERNATIONAL. 2023 ; 43( 1): 47-58.[citado 2025 jun. 25 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57854
Artigo de periodico
Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study (2023)
Doskaliuk, Bohdana; Ravichandran, Naveen ; Sen, Parikshit ; Day, Jessica ; Joshi, Mrudula; Nune, Arvind; Nikiphorou, Elena ; Saha, Sreoshy ; Tan, Ai Lyn; Shinjo, Samuel Katsuyuki
Fonte: Rheumatology international. Unidade: FM
Assuntos: VACINAÇÃO, COVID-19, MIOSITE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DOSKALIUK, Bohdana et al. Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study. Rheumatology international, v. 43, n. 9, p. 1651-1664, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/55968. Acesso em: 25 jun. 2025.
APA
Doskaliuk, B., Ravichandran, N., Sen, P., Day, J., Joshi, M., Nune, A., et al. (2023). Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study. Rheumatology international, 43( 9), 1651-1664. doi:10.1007/s00296-023-05345-y
NLM
Doskaliuk B, Ravichandran N, Sen P, Day J, Joshi M, Nune A, Nikiphorou E, Saha S, Tan AL, Shinjo SK. Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study [Internet]. Rheumatology international. 2023 ; 43( 9): 1651-1664.[citado 2025 jun. 25 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55968
Vancouver
Doskaliuk B, Ravichandran N, Sen P, Day J, Joshi M, Nune A, Nikiphorou E, Saha S, Tan AL, Shinjo SK. Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study [Internet]. Rheumatology international. 2023 ; 43( 9): 1651-1664.[citado 2025 jun. 25 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55968
Artigo de periodico
High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey (2023)
Grignaschi, Silvia; Kim, Minchul; Zanframundo, Giovanni; Ravichandran, Naveen ; Lilleker, James B. ; Sen, Parikshit ; Joshi, Mrudula; Agarwal, Vishwesh ; Kardes, Sinan ; Day, Jessica ; Shinjo, Samuel Katsuyuki
Fonte: Rheumatology international. Unidade: FM
Assuntos: DOENÇAS AUTOIMUNES, QUESTIONÁRIOS, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GRIGNASCHI, Silvia et al. High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey. Rheumatology international, v. 43, n. 9, p. 1637-1649, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/55990. Acesso em: 25 jun. 2025.
APA
Grignaschi, S., Kim, M., Zanframundo, G., Ravichandran, N., Lilleker, J. B., Sen, P., et al. (2023). High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey. Rheumatology international, 43( 9), 1637-1649. doi:10.1007/s00296-023-05344-z
NLM
Grignaschi S, Kim M, Zanframundo G, Ravichandran N, Lilleker JB, Sen P, Joshi M, Agarwal V, Kardes S, Day J, Shinjo SK. High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey [Internet]. Rheumatology international. 2023 ; 43( 9): 1637-1649.[citado 2025 jun. 25 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55990
Vancouver
Grignaschi S, Kim M, Zanframundo G, Ravichandran N, Lilleker JB, Sen P, Joshi M, Agarwal V, Kardes S, Day J, Shinjo SK. High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey [Internet]. Rheumatology international. 2023 ; 43( 9): 1637-1649.[citado 2025 jun. 25 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55990
Artigo de periodico
COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies (2022)
Gil-Vila, Albert; Ravichandran, Naveen; Selva-O'callaghan, Albert; Sen, Parikshit; Nune, Arvind; Gaur, Prithvi Sanjeevkumar; Gonzalez, Raquel Aranega; Lilleker, James B; Joshi, Mrudula; Shinjo, Samuel Katsuyuki
Fonte: Muscle & nerve. Unidade: FM
Assuntos: COVID-19, DERMATOPATIAS, MIOSITE, REUMATOLOGIA, VACINAÇÃO, DOENÇAS AUTOIMUNES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIL-VILA, Albert et al. COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies. Muscle & nerve, v. 66, n. 4, p. 426-437, 2022Tradução . . Disponível em: https://doi.org/10.1002/mus.27681. Acesso em: 25 jun. 2025.
APA
Gil-Vila, A., Ravichandran, N., Selva-O'callaghan, A., Sen, P., Nune, A., Gaur, P. S., et al. (2022). COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies. Muscle & nerve, 66( 4), 426-437. doi:10.1002/mus.27681
NLM
Gil-Vila A, Ravichandran N, Selva-O'callaghan A, Sen P, Nune A, Gaur PS, Gonzalez RA, Lilleker JB, Joshi M, Shinjo SK. COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies [Internet]. Muscle & nerve. 2022 ; 66( 4): 426-437.[citado 2025 jun. 25 ] Available from: https://doi.org/10.1002/mus.27681
Vancouver
Gil-Vila A, Ravichandran N, Selva-O'callaghan A, Sen P, Nune A, Gaur PS, Gonzalez RA, Lilleker JB, Joshi M, Shinjo SK. COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies [Internet]. Muscle & nerve. 2022 ; 66( 4): 426-437.[citado 2025 jun. 25 ] Available from: https://doi.org/10.1002/mus.27681
Artigo de periodico
COVAD survey 2 long-term outcomes: unmet need and protocol (2022)
Fazal, Zoha Zahid; Sen, Parikshit; Joshi, Mrudula; Ravichandran, Naveen; Lilleker, James B; Agarwal, Vishwesh; Kardes, Sinan; Kim, Minchul; Day, Jessica; Shinjo, Samuel Katsuyuki
Fonte: Rheumatology international. Unidade: FM
Assuntos: DOENÇAS AUTOIMUNES, COVID-19, VACINAÇÃO, PANDEMIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAZAL, Zoha Zahid et al. COVAD survey 2 long-term outcomes: unmet need and protocol. Rheumatology international, v. 42, n. 12, p. 2151-2158, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00296-022-05157-6. Acesso em: 25 jun. 2025.
APA
Fazal, Z. Z., Sen, P., Joshi, M., Ravichandran, N., Lilleker, J. B., Agarwal, V., et al. (2022). COVAD survey 2 long-term outcomes: unmet need and protocol. Rheumatology international, 42( 12), 2151-2158. doi:10.1007/s00296-022-05157-6
NLM
Fazal ZZ, Sen P, Joshi M, Ravichandran N, Lilleker JB, Agarwal V, Kardes S, Kim M, Day J, Shinjo SK. COVAD survey 2 long-term outcomes: unmet need and protocol [Internet]. Rheumatology international. 2022 ; 42( 12): 2151-2158.[citado 2025 jun. 25 ] Available from: https://doi.org/10.1007/s00296-022-05157-6
Vancouver
Fazal ZZ, Sen P, Joshi M, Ravichandran N, Lilleker JB, Agarwal V, Kardes S, Kim M, Day J, Shinjo SK. COVAD survey 2 long-term outcomes: unmet need and protocol [Internet]. Rheumatology international. 2022 ; 42( 12): 2151-2158.[citado 2025 jun. 25 ] Available from: https://doi.org/10.1007/s00296-022-05157-6

Unidades USP

ReP

Filtros

Autores

Assuntos

Título da fonte

Agência de fomento

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos